Keros Therapeutics Cash Flow Statement (2019-2025) | KROS

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -3.18M-2.85M-3.55M-2.75M-11.89M-10.76M-12.04M-10.68M-15.88M-15.62M-20.30M-6.94M-24.19M-27.27M-23.51M-29.72M-38.87M-41.34M-43.28M-46.45M-43.11M-45.26M-52.96M-46.03M148.45M-30.70M-7.28M
Depreciation and Depletion 0.04M0.05M0.06M0.06M0.06M0.07M0.07M0.07M0.08M0.09M0.10M0.10M0.11M0.31M0.13M0.13M0.17M0.19M0.21M0.25M0.28M0.31M0.31M0.33M0.34M0.37M0.40M
Share-based Compensation 0.01M0.01M0.02M0.02M0.01M1.14M1.42M1.52M2.49M2.85M3.08M3.29M4.39M4.79M4.75M4.75M5.69M7.04M8.71M7.32M8.07M8.79M8.82M9.20M8.86M8.54M3.99M
Gains from Investment Securities 0.04M-0.04M0.73M-0.76M-0.01M15.43M1.34M5.74M
Cash from Operations -2.51M-5.03M-2.96M-5.50M-8.12M-9.93M-10.86M-7.99M-10.51M-17.64M-14.44M-19.57M-1.43M-22.59M-24.60M-21.44M-34.23M-30.83M-33.98M-25.46M-44.56M-39.80M-30.50M-46.01M161.17M-29.62M3.25M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.04M-0.65M0.79M0.09M0.09M0.05M0.10M0.10M0.10M0.12M0.20M0.20M0.21M0.21M0.32M0.52M0.35M0.34M0.34M0.34M0.35M0.56M0.57M0.58M0.59M0.61M
Depreciation & Amortization (CF) 0.04M0.05M0.06M0.06M0.06M0.07M0.07M0.07M0.08M0.09M0.10M0.10M0.11M0.31M0.13M0.13M0.17M0.19M0.21M0.25M0.28M0.31M0.31M0.33M0.34M0.37M0.40M
Change in Working Capital
Change in Receivables 0.10M-0.10M18.00M-18.00M0.14M0.08M-0.22M0.38M2.35M14.55M-1.48M-12.32M
Change in Account Payables 0.81M-0.22M0.85M-0.13M-0.19M2.96M-3.14M0.43M0.86M-1.64M1.44M0.82M-0.67M4.66M-4.99M0.59M1.32M-0.57M-0.18M1.04M0.02M1.61M-1.59M-0.29M2.02M-1.37M-2.96M
Change in Accured Expenses 0.18M0.08M0.91M0.03M3.27M-2.25M1.66M-0.09M0.89M0.20M1.65M-0.10M0.36M-0.58M1.28M4.26M-1.98M1.17M0.27M5.79M-5.35M0.90M8.71M-1.30M-3.58M2.67M-4.79M
Change in Taxes 10.04M-3.72M-2.17M
Other Working Capital Changes -2.50M-2.50M-2.50M-2.50M0.82M2.63M-1.22M-0.76M-1.07M3.42M0.52M-1.33M-0.76M4.10M-0.29M0.27M4.07M1.49M4.26M-0.54M4.48M6.37M-5.87M5.25M-4.54M2.49M-1.82M
Investing Activities
Capital Expenditures 0.17M0.08M0.02M0.18M0.03M0.03M0.06M0.21M0.51M0.14M0.16M0.15M0.57M0.18M0.35M1.06M0.31M0.55M0.54M0.95M0.31M0.39M0.29M0.56M0.72M0.13M
Cash from Investing Activities -0.17M-0.08M-0.02M-0.18M-0.03M-0.03M-0.06M-0.21M-0.51M-0.14M-0.16M-0.15M-0.57M-0.18M-0.35M-1.06M-0.31M-0.55M-0.54M-0.95M-0.31M-0.39M-0.29M-0.56M-0.72M-0.13M
Financing Activities
Other financing activities 0.22M0.01M0.19M0.10M0.03M0.07M0.13M
Cash from Financing Activities 0.00M0.01M0.00M55.79M100.12M0.01M140.12M0.04M0.06M0.04M28.42M0.12M10.19M48.58M61.42M107.68M1.74M0.28M69.25M156.80M3.53M155.94M75.54M0.00M0.02M0.14M
Additional items
Change in Cash -2.51M-5.20M-3.03M-5.51M47.50M90.17M-10.88M132.07M-10.67M-18.09M-14.55M8.69M-1.46M-12.96M23.80M39.62M72.38M-29.40M-34.25M43.25M111.30M-36.58M125.06M29.25M160.61M-30.33M3.26M
Beginning Cash Balance 23.26M20.75M15.56M12.53M7.02M54.52M144.69M133.81M265.88M255.20M235.90M221.35M230.04M228.59M215.62M239.43M279.05M351.43M322.14M287.89M331.15M442.44M405.63M530.68M559.93M720.54M690.22M
Free Cash Flow -2.51M-5.20M-3.04M-5.52M-8.30M-9.96M-10.89M-8.05M-10.71M-18.15M-14.59M-19.72M-1.57M-23.16M-24.78M-21.79M-35.30M-31.14M-34.53M-26.00M-45.51M-40.11M-30.89M-46.30M160.61M-30.34M3.12M
Net Cash Flow -2.51M-5.20M-3.03M-5.51M47.50M90.17M-10.88M132.07M-10.67M-18.09M-14.55M8.69M-1.46M-12.96M23.80M39.62M72.38M-29.40M-34.25M43.25M111.30M-36.58M125.06M29.25M160.61M-30.33M3.26M